- ►clinchem.org GM Reaven - Clinical chemistry, 2005 - Am Assoc Clin Chem Values for insulin-mediated glucose disposal vary continuously throughout a population of apparently
healthy individuals, with at least a sixfold variation between the most insulin sensitive and most
insulin resistant of these ... Cited by 248 - Related articles - All 5 versions
- ►onlinejacc.org SM Grundy - Journal of the American College of Cardiology, 2006 - Elsevier The metabolic syndrome is a constellation of risk factors of metabolic origin that are accompanied
by increased risk for cardiovascular disease and type 2 diabetes. These risk factors are atherogenic
dyslipidemia, elevated blood ... Cited by 240 - Related articles - BL Direct - All 22 versions
H Sone, S Mizuno, H Fujii, Y Yoshimura, Y … - Diabetes Care, 2005 - Am Diabetes Assoc OBJECTIVE—The metabolic syndrome (MetS) is believed to be associated with an increased risk of
cardiovascular disease (CVD). Although its prevalence is extremely high among diabetic patients, its
prevalence in those with no history ... Cited by 59 - Related articles - All 5 versions
M Deepa, S Farooq, M Datta, R Deepa, V … - Diabetes/Metabolism … - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets. In
this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the ... Cited by 46 - Related articles - BL Direct - All 3 versions
CA Aguilar-Salinas, R Rojas, FJ Gómez-Pérez, R … - Archives of medical …, 2005 - Elsevier The metabolic syndrome integrates, in a single diagnosis, the manifestations of insulin resistance
that may lead to increased cardiovascular morbidity and precedes type 2 diabetes. Here we discuss
the strengths and limitations of ... Cited by 31 - Related articles - All 13 versions
- ►nursing2008.com GD Kolovou, KK Anagnostopoulou, KD … - The American journal …, 2007 - journals.lww.com The insulin resistance/metabolic syndrome (MetS) is characterized by the variable co-existence of
hyperinsulinemia, obesity, dyslipidemia, and hyper- tension.1,2 Other features of the syndrome
include proinflammatory states, ... Cited by 23 - Related articles - BL Direct - All 8 versions
M Hanefeld, C Koehler, S Gallo, I Benke, P Ott - Cardiovascular diabetology, 2007 - cardiab.com One of the major controversies surrounding the metabolic syndrome (MetS) in type 2 diabetes is
whether its single components act synergistically as risk factors for atherosclerotic vascular
disease (AVD). We aimed to answer ... Cited by 20 - Related articles - Cached - All 10 versions
B Hildrum, A Mykletun, T Hole, K Midthjell, AA … - BMC Public …, 2007 - biomedcentral.com The 2005 International Diabetes Federation (IDF) definition of the metabolic syndrome was designed
to be useful worldwide, but to date few prevalence studies have used that definition in European
populations. We estimated the age- ... Cited by 23 - Related articles - Cached - All 8 versions
J Tuomilehto - Diabetes research and clinical practice, 2005 - Elsevier The metabolic syndrome is a cluster of metabolic abnormalities, including impaired glucose
metabolism, hypertension, dyslipidemia and abdominal obesity. It is a precursor to type 2 diabetes
and a powerful independent risk ... Cited by 17 - Related articles - All 11 versions
M Boronat, R Chirino, VF Varillas, P Saavedra, D … - Diabet. Med, 2005 - pt.wkhealth.com Methods: Cross-sectional population-based study. One thousand and thirty adult subjects were
randomly selected from the local census of Telde, a city located on the island of Gran Canaria.
Participants completed a survey ... Cited by 15 - Related articles - BL Direct - All 5 versions
